Skip to content
facebook
BOS 2022
Conference
Victor Snieckus Memorial Fund
Hybrid event
Venue
Important dates
Organizers
Getting to & around Vilnius
Covid-19
Registration
Abstract submission
Accommodation
Content
Final program
Speakers
Poster sessions
Social events
Vilnius city tour
Partners
Contacts
Photo Gallery
Back to BOS
Search for:
Search
DEVELOPING A SCALABLE ROUTE TO THE PROLINE CORE OF VOXILAPREVIR: AN ACTIVE INGREDIENT IN VOSEVI® FOR THE PAN-GENOTYPIC TREATMENT OF HEPATITIS C
Home
Speakers
Joshua Dunetz
DEVELOPING A SCALABLE ROUTE TO THE PROLINE CORE OF VOXILAPREVIR: AN ACTIVE INGREDIENT IN VOSEVI® FOR THE PAN-GENOTYPIC TREATMENT OF HEPATITIS C
Leave a Reply
Cancel reply
You must be
logged in
to post a comment.
